Surgery Partners, Inc. (NASDAQ:SGRY) Insider Sells $544,327.94 in Stock

Surgery Partners, Inc. (NASDAQ:SGRYGet Rating) insider George Goodwin sold 13,598 shares of the business’s stock in a transaction dated Monday, May 23rd. The stock was sold at an average price of $40.03, for a total transaction of $544,327.94. Following the transaction, the insider now owns 44,392 shares in the company, valued at $1,777,011.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

George Goodwin also recently made the following trade(s):

  • On Thursday, April 21st, George Goodwin sold 25,525 shares of Surgery Partners stock. The shares were sold at an average price of $62.58, for a total transaction of $1,597,354.50.
  • On Thursday, March 17th, George Goodwin sold 10,931 shares of Surgery Partners stock. The shares were sold at an average price of $53.68, for a total transaction of $586,776.08.
  • On Monday, February 28th, George Goodwin sold 3,777 shares of Surgery Partners stock. The stock was sold at an average price of $52.23, for a total transaction of $197,272.71.

NASDAQ SGRY traded up $0.78 on Wednesday, hitting $39.83. 523,977 shares of the company were exchanged, compared to its average volume of 445,316. The company has a market cap of $3.58 billion, a P/E ratio of -75.15, a P/E/G ratio of 10.78 and a beta of 2.76. Surgery Partners, Inc. has a 1-year low of $36.96 and a 1-year high of $69.58. The company has a current ratio of 1.73, a quick ratio of 1.61 and a debt-to-equity ratio of 1.50. The firm has a 50 day moving average of $51.01 and a two-hundred day moving average of $49.62.

Surgery Partners (NASDAQ:SGRYGet Rating) last announced its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.09) EPS for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.02. Surgery Partners had a negative return on equity of 0.46% and a negative net margin of 1.63%. During the same period in the previous year, the firm posted ($0.40) earnings per share. Research analysts anticipate that Surgery Partners, Inc. will post 0.1 EPS for the current fiscal year.

Large investors have recently added to or reduced their stakes in the business. FMR LLC bought a new stake in Surgery Partners in the 1st quarter valued at $6,029,000. Morgan Stanley boosted its stake in Surgery Partners by 4.9% in the second quarter. Morgan Stanley now owns 477,196 shares of the company’s stock valued at $31,791,000 after buying an additional 22,352 shares in the last quarter. Barclays PLC boosted its stake in Surgery Partners by 257.4% in the third quarter. Barclays PLC now owns 14,339 shares of the company’s stock valued at $607,000 after buying an additional 10,327 shares in the last quarter. Teacher Retirement System of Texas boosted its stake in shares of Surgery Partners by 57.8% during the third quarter. Teacher Retirement System of Texas now owns 5,136 shares of the company’s stock valued at $217,000 after purchasing an additional 1,881 shares in the last quarter. Finally, AlphaCrest Capital Management LLC boosted its stake in shares of Surgery Partners by 35.6% during the third quarter. AlphaCrest Capital Management LLC now owns 7,000 shares of the company’s stock valued at $296,000 after purchasing an additional 1,836 shares in the last quarter.

A number of research analysts have commented on SGRY shares. Citigroup increased their price objective on shares of Surgery Partners from $61.00 to $64.00 in a research note on Wednesday, May 4th. JPMorgan Chase & Co. increased their price objective on shares of Surgery Partners from $50.00 to $55.00 and gave the stock a “neutral” rating in a report on Wednesday, March 2nd. Royal Bank of Canada lowered their target price on shares of Surgery Partners from $70.00 to $65.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 1st. StockNews.com raised shares of Surgery Partners from a “sell” rating to a “hold” rating in a research note on Thursday, May 12th. Finally, Benchmark lifted their price objective on shares of Surgery Partners from $65.00 to $72.00 in a research note on Wednesday, May 4th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $60.11.

Surgery Partners Company Profile (Get Rating)

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

See Also

Insider Buying and Selling by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.